Chemical Name: (2S)-1-N-[4-Methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide. Alternate Names: NVP-BYL719, BYL719
PI3K inhibitor
Molecular Weight:
441.47
Purity:
>98% by HPLC NMR (Conforms)
Form:
White solid
CAS Number:
[1217486-61-7]
Formula:
C19H22F3N5O2S
Application Notes:
Alpelisib is a potent and selective (IC50s = 7.4 nM PI3Kalpha, 2.2 µM PI3Kß, 1.2 µM PI3KIdelta, 50-fold selectivity against 442 tested kinases) PI3Kalpha inhibitor.1 Approved for use in the treatment of HR(+), HER2(-), PIK3CA-mutated breast cancer. Alpelisib has been used in combination with various chemotherapeutics to treat ovarian2, colorectal3, kidney4, bladder5, and head and neck6 cancers.
* VAT and and shipping costs not included. Errors and price changes excepted